Private Equity
LPs and GPs are increasingly divided on whether certain investment behaviours are truly beneficial to their relationship, writes Jennifer Choi, chief executive of the Institutional Limited Partners Association.
4 min read · 05 March 2026
GPs seek to downplay fears that execs will lose roles to AI; consolidation is creating GP selection headaches for LPs; why New Mountain is convinced CVs are here to stay.
5 min read · 05 March 2026
GP-led secondaries would appear to provide an obvious route to liquidity for staking investors but there are some issues to iron out.
6 min read · 05 March 2026
GP-led deal volume hit an all-time high in 2025, but record growth doesn’t necessarily equate to LP satisfaction with continuation vehicle processes.
7 min read · 05 March 2026
From CVs on CVs to greater specialisation, secondaries professionals who have previously featured on our rising stars list share their insights on the market’s evolution.
6 min read · 05 March 2026
GP-led deals in the region remained a fraction of the global market in 2025.
5 min read · 05 March 2026
More creativity in the impact secondaries market could help boost commitments from liquidity-constrained LPs and allow for longer investment runways.
3 min read · 05 March 2026
With evergreen fund investment in GP-led deals on the rise, how compatible are these transactions with vehicles that offer investors a degree of periodic liquidity and, in most cases, diversified exposures?
7 min read · 05 March 2026
The GP-led market is going from strength to strength, but there are still challenges to address.
4 min read · 05 March 2026
Despite economic headwinds, geopolitical uncertainty and more, there’s still strong appetite for North American secondaries this year.
3 min read · 05 March 2026